The following report offers an overview of both the macro and micro-economic factors that drive the pharmaceutical industry with a brief insight into how these levers impact the key players and decisions in the sector. The report will also relate the key drivers of the industry to the pharmaceutical industry in Ireland and how it is facing these global challenges. Historically, the sector was dominated by large scale bulk compound manufacture but this has evolved into a diverse range of complex technologies
Words: 2748 - Pages: 11
Indian Pharma – likely future trends Years back, Isaac Asimov said, “Life is pleasant. Death is peaceful. It's the transition that's troublesome.” While it may not be a matter of life and death for the Indian pharma industry, it certainly is the transition time and like any transition, it has its pain, as well as gain. Indian pharma has enjoyed a decadal growth rate of ≈13%, except for the year 2013, when due to large number of formulations coming under price control, growth rate plummeted by more
Words: 929 - Pages: 4
research, development, manufacture and marketing of medicines, vaccines, medical devices, and nutritional products for humans and animals. Though, this multi-billion dollar industry includes large ethical drug multi-nationals (often referred to as Big Pharma), mid-sized specialty pharmaceutical companies, manufacturers of generics, small biotechnology and biopharmaceutical firms, and service companies, 1 for the purpose of this paper, the emphasis will be mainly on drug makers. 2. History/Overview
Words: 2796 - Pages: 12
com/reports/680564/ The Top Five Global Pharma Companies; Where they are Now and Where they heading? Description: A mini report identifying drivers and barriers to sustaining financial performance over the next 5 years for the top five global pharmaceutical companies -Johnson & Johnson, Pfizer, GSK, Novartis and Sanofi-Aventis This report presents the cases of the top five global pharma companies: J&J, Pfizer, GSK, Novartis and SanofiAventis and identifies their key growth areas. Pooling data from 6 major
Words: 1107 - Pages: 5
Submitted By Ravela Madhurika- 1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ...........................................................
Words: 7934 - Pages: 32
Pharmaceutical and Medical Products Practice India Pharma 2020 Propelling access and acceptance, realising true potential The report is furnished to the recipient for information purposes only. Each recipient should conduct its own investigation and analysis of any such information contained in this report. No recipient is entitled to rely on the work of McKinsey & Company, Inc. contained in this report for any purpose. McKinsey & Company, Inc. makes no representations or warranties regarding
Words: 9542 - Pages: 39
brief profiles of key players in the sector to facilitate future business development activities in this space, and compilation of major global transactions in order to analyse transaction metrics and potential Scope – Following was the broad scope of the report 1. Overview of the global nutraceuticals market covering 1.1. Market Size and Growth 1.2. Key Markets 2. Detailed section on the Indian Nutraceuticals market covering 2.1. Market Size and Growth 2.2. Key Segments 2.3. Drivers 2.4. Challenges
Words: 9552 - Pages: 39
Cheung Kong MBA Thesis Oral Defense Jul 30/31, 2011 Takeda’s Vaccine Business Strategy CKMBA0621 Jenny Jie PENG 彭洁 Agenda 1. 2. 3. Why Vaccines? – – Key Trends – – – – Maximize value of current assets Major Drivers for Growth Why Takeda? Why Vaccines Create Opportunity for Takeda Current pipeline opportunities Short and long term growth potential Capability mapping for future growth How? Roadmap to Establish Takeda’s Global Vaccines Business – – – Opportunities and barriers to entry
Words: 1687 - Pages: 7
Market intelligence > Top ten global pharma Top ten global pharma Dr Vishal Agrawal, project manager, and Sunehli Jamwal, analyst, from GlobalData, highlight the top ten pharmaceutical companies by 2011 revenue. Pfizer 1 Johnson & Johnson 2 US pharmaceutical giant Pfizer maintained its top position in 2011 with stipulated revenue of $67.4 billion, up by 1% compared with $67.1 billion in 2010. The company’s new marketing strategy, coupled with focused organisational, financial and
Words: 1560 - Pages: 7
2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division of XYZ, one
Words: 5468 - Pages: 22
